U.S., Feb. 14 -- ClinicalTrials.gov registry received information related to the study (NCT07409857) titled 'International Registry of Dengue Infection in Congenital Bleeding Disorders (DengueCBDR)' on Jan. 20.
Brief Summary: Dengue fever, a viral infection transmitted by Aedes mosquitoes, is a major health issue in tropical and subtropical regions. Around 20-30% of symptomatic patients developed Dengue Hemorrhagic Fever (DHF), which leads to impaired hemostasis, subsequently increasing the risk of bleeding.
The hemostatic abnormalities associated with dengue infection included vascular permeability, platelet dysfunction, and coagulation defects. Therefore, Individuals with underlying bleeding disorders are at increased risk of bleeding. ...